🤖Artificial Intelligence
Mind-altering substances are (still) falling short in clinical trials
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, inclu
J
Jessica Hamzelou
📡
Original Source
MIT Technology Review
https://www.technologyreview.com/2026/03/20/1134419/psychedelics-overhyped-psilocybin-depression-placebo/This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…
Tags:#ai#mit-technology-review
Found this useful? Share it!
Read the Full Story
Continue reading on MIT Technology Review
Related Stories
🤖
🤖Artificial Intelligence
The Download: OpenAI is building a fully automated researcher, and a psychedelic trial blind spot
about 2 hours ago
🤖
🤖Artificial Intelligence
The best AI investment might be in energy tech
about 3 hours ago
🤖
🤖Artificial Intelligence
OpenAI is throwing everything into building a fully automated researcher
about 3 hours ago
🤖
🤖Artificial Intelligence
Jeff Bezos reportedly wants $100 billion to buy and transform old manufacturing firms with AI
about 17 hours ago